Autologous Stem-Cell Transplantation for Hodgkin’s Disease: Results and Prognostic Factors in 494 Patients From the Grupo Español de Linfomas/Transplante Autólogo de Médula Ósea Spanish Cooperative GroupAnna Sureda, E. Condé, R Cabrera et al.|Journal of Clinical Oncology|2001Cited by 233
Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapseAnna Sureda, E. Condé, M. Constans et al.|Annals of Oncology|2005Cited by 220
Nonmyeloablative Stem Cell Transplantation Is an Effective Therapy for Refractory or Relapsed Hodgkin Lymphoma: Results of a Spanish Prospective Cooperative ProtocolIván Alvarez, Jorge Sierra, Anna Sureda et al.|Transplantation and Cellular Therapy|2006Cited by 142
Reduced‐intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long‐term outcomesKarl S. Peggs, Anna Sureda, Wendi Qian et al.|British Journal of Haematology|2007Cited by 106
High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative GroupMarı́a Dolores Caballero, E. Condé, Josè Antonio Pérez-Simón et al.|Annals of Oncology|2002Cited by 70